Answer given by Mr Dalli on behalf of the Commission (26 October 2010) On 22 July 2009 the Commission adopted a Communication from the Commission to the European Parliament and the Council on a European initiative on Alzheimer’s disease and other dementias COM(2009)380 not published in OJ. . This sets out EU support to national efforts in four key areas: (1) prevention, (2) coordinating research across Europe, (3) spreading best practice for treatment and care and (4) developing a common approach to ethical questions — rights, autonomy, and dignity of people with dementia. The specific actions addressing the European Commission supports the following: the Joint Action ‘ALzheimer COoperative Valuation in Europe’ (Alcove) under the Health Programme; The Commission also provides funding for research addressing neurodegenerative diseases and in particular Alzheimer's disease through the 7th Framework Programme for Research and Technological Development. To date, 36 projects with an EU contribution of more than EUR 173 million have been funded. With one of these projects the Commission is supporting a pilot Joint Programming initiative on neurodegenerative diseases in particular Alzheimer on research to tackle such neurodegenerative diseases, involving 23 EU countries; Additional funding for Alzheimer research is provided through the Innovative Medicines Initiative http://www.imi.europa.eu/ , jointly funded by the European Union and the European pharmaceutical industry association EFPIA, in particular the PharmaCOG project http://cordis.europa.eu/wire/index.cfm?fuseaction=article.Detail&rcn=19336 . The PharmaCOG project (Prediction of Cognitive properties of new drug candidates for neurodegenerative diseases in early clinical development) aim to validate tools necessary to streamline Alzheimer's disease drug discovery and accelerate the development of effective medicines; and support to Alzheimer Europe, the main platform of patient's associations in the European Union, under the Health Programme. Further information is available at: http://ec.europa.eu/health-eu/europe_for_patients/alzheimer_disease_dementias/index_en.htm